ZIMMER BIOMET HOLDINGS INC's ticker is ZBH and the CUSIP is 98956P102. A total of 26 filers reported holding ZIMMER BIOMET HOLDINGS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Centre Asset Management, LLC | 83,753 | $10,193 | 2.46% |
| Covea Finance | 143,300 | $17,439,610 | 0.85% |
| ST GERMAIN D J CO INC | 82,363 | $10,023,577 | 0.52% |
| InTrack Investment Management Inc | 4,354 | $529,823 | 0.40% |
| Boltwood Capital Management | 5,581 | $679,208 | 0.22% |
| Riverwater Partners LLC | 2,252 | $274,068 | 0.22% |
| Anchor Investment Management, LLC | 14,353 | $1,746,786 | 0.20% |
| TRUST CO OF TOLEDO NA /OH/ | 7,378 | $897,903 | 0.16% |
| Curbstone Financial Management Corp | 4,226 | $514,304 | 0.12% |
| CHEMUNG CANAL TRUST CO | 4,458 | $542,541 | 0.11% |
| Czech National Bank | 36,601 | $4,454,342 | 0.06% |
| CANANDAIGUA NATIONAL BANK & TRUST CO | 2,800 | $340,760 | 0.05% |
| Montecito Bank & Trust | 1,975 | $240,358 | 0.05% |
| WealthPlan Investment Management, LLC | 1,900 | $231,227 | 0.04% |
| Peoples Bank/KS | 355 | $43,203 | 0.04% |
| OPTIMUM INVESTMENT ADVISORS | 550 | $66,935 | 0.03% |
| M&R CAPITAL MANAGEMENT INC | 747 | $90,910 | 0.02% |
| DnB Asset Management AS | 31,602 | $3,845,963 | 0.02% |
| MASSMUTUAL TRUST CO FSB/ADV | 4,613 | $561,402 | 0.02% |
| Symmetry Partners, LLC | 2,565 | $312 | 0.02% |
About ZIMMER BIOMET HOLDINGS INC
Zimmer Biomet Holdings Inc. is a leading medical device company that specializes in orthopedic implants and related surgical products. The company has a long history of innovation and has been at the forefront of the orthopedic industry for over 90 years.
Zimmer Biomet's products are used in a wide range of orthopedic procedures, including joint replacement surgeries, spine surgeries, and trauma surgeries. The company's products are designed to improve patient outcomes and reduce the cost of healthcare.
Zimmer Biomet has a strong presence in the global market, with operations in more than 25 countries. The company's products are sold in over 100 countries, and it has a strong reputation for quality and reliability.
In recent years, Zimmer Biomet has faced some challenges, including regulatory issues and product recalls. However, the company has taken steps to address these issues and has implemented new quality control measures to ensure that its products meet the highest standards.
Despite these challenges, Zimmer Biomet remains a leader in the orthopedic industry, and its products continue to be in high demand. The company's strong reputation and commitment to innovation make it a solid choice for investors looking to invest in the medical device industry.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
External links
This page lists ZIMMER BIOMET HOLDINGS INC's shareholders in Q4 2023. To view ZIMMER BIOMET HOLDINGS INC's shareholder history, click here.